Doctors typically begin patients on 0.25 mg once a week for the first month. After the introductory phase, the dosage ...

With India facing over 101 million cases of diabetes and rising obesity levels, the drug could play a significant role in ...

Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by rival Eli Lilly. The Danish drugmaker said Tuesday that pre-filled pens and ...

The blockbuster drug by Novo Nordisk will be marketed for adults with type-2 diabetes, unlike in the US and Europe where it is also sold as Wegovy for weight loss. Ozempic is a once-weekly injectable ...

Medtronic. Dexcom. Abbott. Sanofi. Google. A lot of very large, well-known companies are investing heavily into innovating the diabetes space, and that innovation is exciting. But a disproportionate ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting ...

The "Japan Insulin Pen Market Growth Outlook 2025-2033" has been added to ResearchAndMarkets.com's offering. The Japan Insulin Pen Market is forecasted to rise from US$ 304.26 Million in 2024 to US$ ...

Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push ...